Daniela Rubino - Publications

Molecular Characterization of Endometrial Cancer Using a Laboratory-Developed Multi-Gene NGS Panel.

Journal: International journal of molecular sciences

Published: June 06, 2026

Association between pathologic chemotherapy response score and pattern of recurrence in advanced high-grade serous ovarian cancer.

Journal: The oncologist

Published: January 11, 2026

Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype.

Journal: Histopathology

Published: June 11, 2025

Continuing chemotherapy beyond 6 cycles increases the chances of complete cytoreduction surgery in patients with advanced ovarian cancer.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: April 21, 2025

Defining Predictive Factors for Permanent Chemotherapy-Induced Alopecia: Trichoscopy, Reflectance Confocal Microscopy and Histopathology Study on 77 Patients.

Journal: Dermatology and therapy

Published: January 17, 2025

Management of cutaneous adverse events caused by antineoplastic therapies: a single-center experience.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: November 05, 2023

Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: July 10, 2023

Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma.

Journal: Journal of personalized medicine

Published: February 27, 2023

Characterization of BRCA Deficiency in Ovarian Cancer.

Journal: Cancers

Published: January 31, 2023

Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice.

Journal: Frontiers in medicine

Published: January 17, 2023

Management of malignant cutaneous wounds in oncologic patients.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: January 16, 2022

Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experience.

Journal: Tumori

Published: December 19, 2019